What you should know:
1. Bausch split the notes so half will be due in 2028 and half will be due in 2029.
2. Bausch’s outstanding 2023 senior notes are at 5.5 percent and 5.88 percent interest.
3. Bausch CEO Joseph Papa has made significant strides in recent years to pay down the company’s large amount of debt. Bausch Health was previously known as Valeant Pharmaceuticals.
More articles on supply chain:
Healthcare experts discuss investor interest in orthopedics — 5 key points
University of Maryland children’s medical device competition reveals 5 winners
RTI Surgical reports $9.1M net loss in Q1: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.